Although p53 plays a tumor-suppressor role against tumorigenesis, over 50% of breast cancer patients and 80% of triple-negative breast cancer (TNBC) patients bear mutant p53, demonstrating that mutant p53 plays a vital role in breast cancer progression [45]. This evidence concerns the gene TP53 and triple-negative breast carcinoma.